Consensus Metagenomi, Inc.

Equities

MGX

US59102M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
7 ^USD	0.00%		+6.87%	0.00%

May. 07	HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target	MT
May. 03	North American Morning Briefing : Apple, Amgen -2-	DJ

Evolution of the average Target Price on Metagenomi, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a87af185882150b375fba77d6738fd0e.322JURzgQPuPOlZSGkO1_qRlL_JTDLpo1KKGKbrmybA.sRS9JW6QC676fQEYbzfdkO8VH74dQNYu-cqzT_msgoHrVLgBK4V3o-h4Hw~ca3b4bec260e4903d19e9b9307d33619

Analyst Recommendations on Metagenomi, Inc.

HC Wainwright Starts Metagenomi With Buy Rating, $10 Price Target	May. 07	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT
JPMorgan Downgrades Metagenomi to Neutral, Price Target at $6	May. 02	MT
TD Cowen Initiates Metagenomi With Outperform Rating	Mar. 05	MT
Jefferies Starts Metagenomi With Buy Rating, $23 Price Target	Mar. 05	MT
BMO Capital Starts Metagenomi With Outperform Rating, $22 Price Target	Mar. 05	MT
Wells Fargo Starts Metagenomi With Overweight Rating, $25 Price Target	Mar. 05	MT
JPMorgan Starts Metagenomi With Overweight Rating, $16 Price Target	Mar. 05	MT
Chardan Starts Metagenomi With Buy Rating, Price Target is $21	Mar. 05	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7 USD

Average target price

16.83 USD

Spread / Average Target

+140.48%

High Price Target

25 USD

Spread / Highest target

+257.14%

Low Price Target

6 USD

Spread / Lowest Target

-14.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Metagenomi, Inc.

HC Wainwright
Chardan Research
JPMorgan Chase
TD Cowen
Wells Fargo Securities
BMO Capital
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar